Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Simona Stäger is active.

Publication


Featured researches published by Simona Stäger.


Immunity | 2008

ArticlePosttranscriptional Regulation of Il10 Gene Expression Allows Natural Killer Cells to Express Immunoregulatory Function

Asher Maroof; Lynette Beattie; Soombul Zubairi; Mattias Svensson; Simona Stäger; Paul M. Kaye

Natural killer (NK) cells play a well-recognized role in early pathogen containment and in shaping acquired cell-mediated immunity. However, indirect evidence in humans and experimental models has suggested that NK cells also play negative regulatory roles during chronic disease. To formally test this hypothesis, we employed a well-defined experimental model of visceral leishmaniasis. Our data demonstrated that NKp46(+)CD49b(+)CD3(-) NK cells were recruited to the spleen and into hepatic granulomas, where they inhibited host protective immunity in an interleukin-10 (IL-10)-dependent manner. Although IL-10 mRNA could be detected in activated NK cells 24 hr after infection, the inhibitory function of NK cells was only acquired later during infection, coincident with increased IL-10 mRNA stability and an enhanced capacity to secrete IL-10 protein. Our data support a growing body of literature that implicates NK cells as negative regulators of cell-mediated immunity and suggest that NK cells, like CD4(+) T helper 1 cells, may acquire immunoregulatory functions as a consequence of extensive activation.


Infection and Immunity | 2003

Both Interleukin-4 (IL-4) and IL-4 Receptor α Signaling Contribute to the Development of Hepatic Granulomas with Optimal Antileishmanial Activity

Simona Stäger; James Alexander; K. Christine Carter; Frank Brombacher; Paul M. Kaye

ABSTRACT The roles of interleukin-4 (IL-4) and IL-13 in the regulation of immunity to Leishmania donovani infection are still poorly understood. Here we show that the increased parasite load observed in IL-4−/− and IL-4 receptor α−/− mice correlates with retarded granuloma maturation and antileishmanial activity and that the increased parasite load observed in IL-4 receptor α−/− mice correlates with increased NOS2 expression and decreased serum gamma interferon levels. IL-4 and IL-13 appear to play little role in regulating collagen deposition in L. donovani-induced granulomas.


European Journal of Immunology | 2006

Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells.

Simona Stäger; Asher Maroof; Soombul Zubairi; Stephanie L. Sanos; Manfred Kopf; Paul M. Kaye

Adoptive dendritic cell (DC) immunotherapy provides a useful experimental tool to evaluate immunoregulation in vivo and has previously been successfully used to enhance host resistance in a variety of experimental models of leishmaniasis. Here, we used this approach to identify IL‐6 and IL‐12p40 as critical cytokines that cooperate to mediate host protection to Leishmania donovani but which act independently to regulate expansion of IL‐10+ CD4+ T cells, shown here for the first time to be associated with this infection. Adoptive transfer of LPS‐activated bone marrow‐derived DC (BMDC) from wild‐type mice was therapeutically beneficial and led to enhanced resistance as measured by spleen parasite burden. In contrast, IL‐6‐ or IL‐12p40‐deficient BMDC had no protective benefit, indicating that production of both cytokines was essential for the therapeutic efficacy of DC. IL‐10 production by CD25– FoxP3– IL‐10+ CD4+ T cells is a strong correlate of disease progression, and BMDC from wild‐type mice inhibited expansion of these cells. Strikingly, IL‐12‐deficient BMDC could also inhibit the expansion of this T cell population whereas IL‐6‐deficient BMDC could not, indicating that IL‐6 played a key role in this aspect of DC function in vivo. Breadth of cytokine production is thus an important factor when considering strategies for DC‐based interventions.


Journal of Immunology | 2012

Marginal Zone B Cells Regulate Antigen-Specific T Cell Responses during Infection

Rashmi Bankoti; Kshitiz Gupta; Andre Levchenko; Simona Stäger

Marginal zone B cells (MZB) participate in the early immune response to several pathogens. In this study, we show that in μMT mice infected with Leishmania donovani, CD8 T cells displayed a greater cytotoxic potential and generated more effector memory cells compared with infected wild type mice. The frequency of parasite-specific, IFN-γ+ CD4 T cells was also increased in μMT mice. B cells were able to capture parasites, which was associated with upregulation of surface IgM and MyD88-dependent IL-10 production. Moreover, MZB presented parasite Ags to CD4 T cells in vitro. Depletion of MZB also enhanced T cell responses and led to a decrease in the parasite burden but did not alter the generation of effector memory T cells. Thus, MZB appear to suppress protective T cell responses during the early stages of L. donovani infection.


PLOS Pathogens | 2011

Critical role of IRF-5 in the development of T helper 1 responses to Leishmania donovani infection.

Andrea Paun; Rashmi Bankoti; Trupti Joshi; Paula M. Pitha; Simona Stäger

The transcription factor Interferon Regulatory Factor 5 (IRF-5) has been shown to be involved in the induction of proinflammatory cytokines in response to viral infections and TLR activation and to play an essential role in the innate inflammatory response. In this study, we used the experimental model of visceral leishmaniasis to investigate the role of IRF-5 in the generation of Th1 responses and in the formation of Th1-type liver granulomas in Leishmania donovani infected mice. We show that TLR7-mediated activation of IRF-5 is essential for the development of Th1 responses to L. donovani in the spleen during chronic infection. We also demonstrate that IRF-5 deficiency leads to the incapacity to control L. donovani infection in the liver and to the formation of smaller granulomas. Granulomas in Irf5-/- mice are characterized by an increased IL-4 and IL-10 response and concomitant low iNOS expression. Collectively, these results identify IRF-5 as a critical molecular switch for the development of Th1 immune responses following L. donovani infections and reveal an indirect role of IRF-5 in the regulation of iNOS expression.


Infection and Immunity | 2006

Adoptive Immunotherapy against Experimental Visceral Leishmaniasis with CD8+ T Cells Requires the Presence of Cognate Antigen

Rosalind Polley; Simona Stäger; Sara Prickett; Asher Maroof; Soombul Zubairi; Deborah F. Smith; Paul M. Kaye

ABSTRACT CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.


Frontiers in Immunology | 2012

CD8+ T Cells in Leishmania Infections: Friends or Foes?

Simona Stäger; Sima Rafati

Host protection against several intracellular pathogens requires the induction of CD8+ T cell responses. CD8+ T cells are potent effector cells that can produce high amounts of pro-inflammatory cytokines and kill infected target cells efficiently. However, a protective role for CD8+ T cells during Leishmania infections is still controversial and largely depends on the infection model. In this review, we discuss the role of CD8+ T cells during various types of Leishmania infections, following vaccination, and as potential immunotherapeutic targets.


Proceedings of the National Academy of Sciences of the United States of America | 2009

A human IL10 BAC transgene reveals tissue-specific control of IL-10 expression and alters disease outcome

Dilini Ranatunga; Christian M. Hedrich; Daniel W. McVicar; Nathan Nowak; Trupti Joshi; Lionel Feigenbaum; Lindsay R. Grant; Simona Stäger; Jay H. Bream

Interleukin (IL)-10 is an immunoregulatory cytokine that is produced by diverse cell populations. Studies in mice suggest that the cellular source of IL-10 is a key determinant in various disease pathologies, yet little is known regarding the control of tissue-specific human IL-10 expression. To assess cell type-specific human IL-10 regulation, we created a human IL-10 transgenic mouse with a bacterial artificial chromosome (hIL10BAC) in which the IL10 gene is positioned centrally. Since human IL-10 is biologically active in the mouse, we could examine the in vivo capacity of tissue-specific human IL-10 expression to recapitulate IL-10-dependent phenotypes by reconstituting Il10−/− mice (Il10−/−/hIL10BAC). In response to LPS, Il10−/−/hIL10BAC mice proficiently regulate IL-10-target genes and normalize sensitivity to LPS toxicity via faithful human IL-10 expression from macrophages and dendritic cells. However, in the Leishmania donovani model of pathogen persistence, Il10−/−/hIL10BAC mice did not develop the characteristic IL-10+IFN-γ+CD4 T cell subset thought to mediate persistence and, like Il10−/− mice, cleared the parasites. Furthermore, the IL-10-promoting cytokine IL-27 failed to regulate transgenic human IL-10 production in CD4+ T cells in vitro which together suggests that the hIL10BAC encodes for weak T cell-specific IL-10 expression. Thus, the hIL10BAC mouse is a model of human gene structure and function revealing tissue-specific regulatory requirements for IL-10 expression which impacts disease outcomes.


Journal of Tropical Medicine | 2012

Differential Regulation of the Immune Response in the Spleen and Liver of Mice Infected with Leishmania donovani.

Rashmi Bankoti; Simona Stäger

Immunity to pathogens requires generation of effective innate and adaptive immune responses. Leishmania donovani evades these host defense mechanisms to survive and persist in the host. A better understanding and identification of mechanisms that L. donovani employs for its survival is critical for developing novel therapeutic interventions that specifically target the parasite. This paper will highlight some of the mechanisms that the parasite utilizes for its persistence and also discuss how the immune response is regulated.


Journal of Immunology | 2014

Leishmania Promastigotes Induce Cytokine Secretion in Macrophages through the Degradation of Synaptotagmin XI

Guillermo Arango Duque; Mitsunori Fukuda; Salvatore J. Turco; Simona Stäger; Albert Descoteaux

Synaptotagmins (Syts) are type-I membrane proteins that regulate vesicle docking and fusion in processes such as exocytosis and phagocytosis. We recently discovered that Syt XI is a recycling endosome- and lysosome-associated protein that negatively regulates the secretion of TNF and IL-6. In this study, we show that Syt XI is directly degraded by the zinc metalloprotease GP63 and excluded from Leishmania parasitophorous vacuoles by the promastigotes surface glycolipid lipophosphoglycan. Infected macrophages were found to release TNF and IL-6 in a GP63-dependent manner. To demonstrate that cytokine release was dependent on GP63-mediated degradation of Syt XI, small interfering RNA-mediated knockdown of Syt XI before infection revealed that the effects of small interfering RNA knockdown and GP63 degradation were not cumulative. In mice, i.p. injection of GP63-expressing parasites led to an increase in TNF and IL-6 secretion and to an augmented influx of neutrophils and inflammatory monocytes to the inoculation site. Both of these cell types have been shown to be infection targets and aid in the establishment of infection. In sum, our data revealed that GP63 induces proinflammatory cytokine release and increases infiltration of inflammatory phagocytes. This study provides new insight on how Leishmania exploits the immune response to establish infection.

Collaboration


Dive into the Simona Stäger's collaboration.

Top Co-Authors

Avatar

Akil Hammami

Institut national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Tania Charpentier

Institut national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Trupti Joshi

Johns Hopkins University

View shared research outputs
Top Co-Authors

Avatar

Paul M. Kaye

Hull York Medical School

View shared research outputs
Top Co-Authors

Avatar

Aymeric Fabié

Institut national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Belma Melda Abidin

Institut national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sasha Silva-Barrios

Institut national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar

Xavier Dagenais-Lussier

Institut national de la recherche scientifique

View shared research outputs
Researchain Logo
Decentralizing Knowledge